Anti-filamentous actin antibodies characterize autoimmune hepatitis type 1 (AIH-1). Recently, the binding domain of α-actinin on actin was shown to be a predominant epitope. To test this reactivity, an anti-α-actinin enzyme-linked immunosorbent assay was developed, and positivity confirmed by Western blot. Anti-α-actinin antibody was found in 21/50 (42%) of AIH-1 patients, compared with 52/401 (12.9%) of liver disease control patients, and with 6/200 (6%) of blood donors. Anti-filamentous and anti-α-actinin activities were found specifically together in 66% of anti-filamentous-positive AIH-1 patients. This combination of specificities reflected clinical and histological disease activity, short duration and absence of treatment. Finally, using an actin-α-actinin complex assay, the binding of anti-filamentous actin to α-actinin-binding domain on actin was demonstrated, as well as that of anti-α-actinin on the actin-binding domain of α-actinin. Thus, the frequent combination of anti-filamentous and anti-α-actinin antibodies seems to be the hallmark of activity in AIH-1.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
The IAHG score includes many parameters (sex, IgG increase, positivity for autoantibodies) including biopsy findings.
Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, Chapman RW, Cooksley WG, Czaja AJ, Desmet VJ, Donaldson PT, Eddleston AL, Fainboim L, Heathcote J, Homberg JC, Hoofnagle JH, Kakumu S, Krawitt EL, Mackay IR, MacSween RN, Maddrey WC, Manns MP, McFarlane IG, Meyer zum Buschenfelde KH, Zeniya M, et al.: International Autoimmune Hepatitis Group Report: Review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 31:929–938, 1999
Granito A, Muratori L, Muratori P, Pappas G, Guidi M, Cassani F, Volta U, Ferri A, Lenzi M, Bianchi FB: Antibodies to filamentous actin (F-actin) in type 1 autoimmune hepatitis. J Clin Pathol 59:280–284, 2006
Czaja AJ, Morshed SA, Parveen S, Nishioka M: Antibodies to single-stranded and double-stranded DNA in antinuclear antibody-positive type 1-autoimmune hepatitis. Hepatology 26:567–572, 1997
Zachou K, Rigopoulou E, Dalekos GN: Autoantibodies and autoantigens in autoimmune hepatitis: Important tools in clinical practice and to study pathogenesis of the disease. J Autoimmune Dis 1:2, 2004
Ma Y, Okamoto M, Thomas MG, Bogdanos DP, Lopes AR, Portmann B, Underhill J, Durr R, Mieli-Vergani G, Vergani D: Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease. Hepatology 36:658–664, 2002
Liaskos C, Bogdanos PD, Davies ET, Dalekos GN: Diagnostic relevance of anti-filamentous actin antibodies in autoimmune hepatitis. J Clin Pathol, in press
Czaja AJ, Cassani F, Cataleta M, Valentini P, Bianchi FB: Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis. Hepatology 24:1068–1073, 1996
Jesaitis AJ, Gizachew D, Dratz EA, Siemsen DW, Stone KC, Burrit JB: Actin surface structure revealed by antibody imprints: Evaluation of phage-display analysis of anti-actin antibodies. Protein Sci 8:760–770, 1999
Zamanou A, Samiotaki M, Panayotou G, Margaritis L, Lymberi P: Fine specificity and subclasses of IgG anti-actin autoantibodies differ in health and disease. J Autoimmun 20:333–344, 2003
McGough A, Way M, DeRosier D: Determination of the alpha-actinin-binding site on actin filaments by cryoelectron microscopy and image analysis. J Cell Biol 126:433–443, 1994
Girard D, Senecal JL: Anti-microfilament IgG antibodies in normal adults and in patients with autoimmune diseases: Immunofluorescence and immunoblotting analysis of 201 subjects reveals polyreactivity with microfilament-associated proteins. Clin Immunol Immunopathol 74:193–201, 1995
Otey CA, Carpen O: α-Actinin revisited: A fresh look at an old player. Cell Motil Cytoskeleton 58:104–111, 2004
Chan Y, Tong HQ, Beggs AH, Kunkel LM: Human skeletal muscle-specific alpha-actinin-2 and -3 isoforms from homodimers and heterodimers in vitro and in vivo. Biochem Biophys Res Commun 248:134–139, 1998
Mills M, Yang N, Weinberger R, Vander Woude DL, Beggs AH, Easteal S, North K: Differential expression of the actin-binding proteins, alpha-actinin-2 and -3, in different species: Implications for the evolution of functional redundancy. Hum Mol Genet 10:1335–1346, 2001
Lan S, Wang H, Jiang H, Mao H, Liu X, Zhang X, Hu Y, Xiang L, Yuan Z: Direct interaction between alpha-actinin and hepatitis C virus NS5B. FEBS Lett 554:289–294, 2003
Renaudineau Y, Croquefer S, Jousse S, Renaudineau E, Devauchelle V, Guéguen P, Hanrotel C, Gilburd B, Saraux A, Shoenfeld Y, Putterman C, Youinou P: Association with α-actinin-binding anti-dsDNA antibody with lupus nephritis. Arthritis Rheum 54:2523–2532, 2006
Kyriakou D, Alexandrakis M, Zachou K, Passam F, Stathakis N, Dalekos GN: Hemopoietic progenitor cells and bone marrow stromal cells in patients with autoimmune hepatitis type 1 and primary biliary cirrhosis. J Hepatol 39:679–685, 2003
Liaskos C, Rigopoulou E, Zachou K, Georgiadou S, Gatselis N, Papamihali R, Dalekos GN: Prevalence and clinical significance of anticardiolipin antibodies in patients with type 1 autoimmune hepatitis. J Autoimmun 24:251–260, 2005
Mason LJ, Ravirajan CT, Rahman A, Putterman C, Isenberg DA: Is alpha-actinin a target for pathogenic anti-DNA antibodies in lupus nephritis? Arthritis Rheum 50:866–870, 2004
Croquefer S, Renaudineau Y, Jousse S, Guéguen P, Ansart S, Saraux A, Youinou P: The anti-alpha-actinin test completes anti-DNA determination in systemic lupus erythematosus. Ann N Y Acad Sci 1050:170–175, 2005
Leibovitch L, George J, Levi Y, Bakimer R, Shoenfeld Y: Anti-actin antibodies in sera from patients with autoimmune liver diseases and patients with carcinomas by ELISA. Immunol Lett 48:129–132, 1995
Dalekos GN, Makri E, Loges S, Obermayer-Straub P, Zachou K, Tsikrikas T, Schmidt E, Papadamou G, Manns MP: Increased incidence of anti-LKM autoantibodies in a consecutive cohort of hepatitis C patients from central Greece. Eur J Gastroenterol Hepatol 14:35–42, 2002
Dalekos GN, Wedemeyer H, Obermayer-Straub P, Kayser A, Barut A, Frank H, Manns MP: Epitope mapping of cytochrome P450 2D6 autoantigen in patients with chronic hepatitis C under α-interferon treatment. J Hepatol 30:366–375, 1999
Bottazzo GF, Florin-Christensen A, Fairfax A, Swana G, Doniach D, Groeschel-Stewart U. Classification of smooth muscle autoantibodies detected by immunofluorescence. J Clin Pathol 29:403–410, 1976
Vergani D, Alvarez F, Bianchi FB, Cançado ELR, Mackay IR, Manns MP, Nishioka M, Penner E: Liver autoimmune serology: A consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group. J Hepatol 41:677–683, 2004
Czaja AJ: Behavior and significance of autoantibodies in type 1 autoimmune hepatitis. J Hepatol 30:394–401, 1999
Vergani D, Mieli-Vergani G, Mondelli M, Portmann B, Eddleston AL: Immunoglobulin on the surface of isolated hepatocytes is associated with antibody-dependent cell-mediated cytotoxicity and liver damage. Liver 7:307–315, 1987
Matsuo I, Ikuno N, Omagari K, Kinoshita H, Oka M, Yamaguchi H, Kohno S, Mackay IR: Autoimmune reactivity of sera to hepatocyte plasma membrane in type 1 autoimmune hepatitis. J Gastroenterol 35:226–234, 2000
Treichel U, McFarlane BM, Seki T, Krawitt EL, Alessi N, Stickel F, McFarlane IG, Kiyosawa K, Furuta S, Freni MA, et al.: Demographics of anti-asialoglycoprotein receptor autoantibodies in autoimmune hepatitis. Gastroenterology 107:799–804, 1994
Wies I, Brunner S, Henninger J, Herkel J, Kanzler S, Meyer zum Buschenfelde KH, Lohse AW: Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis. Lancet 355:1510–1515, 2000
Volkmann M, Martin L, Bäurle A, Heid H, Strassburg CP, Trautwein C, Fiehn W, Manns MP: Soluble liver antigen: Isolation of a 35 kD recombinant protein (SLA-P35) specifically recognizing sera from patients with autoimmune hepatitis type 3. Hepatology 33:591–596, 2001
Costa M, Rodriguez-Sanchez JL, Czaja AJ, Gelpi C: Isolation and characterization of cDNA encoding the antigenic protein of the human tRNP (Ser) Sec complex recognized by autoantibodies from patients with type-1 autoimmune hepatitis. Clin Exp Immunol 121:364–374, 2000
Deocharan B, Qing X, Lichauco J, Putterman C: Alpha-actinin is a cross-reactive renal target for pathogenic anti-DNA antibodies. J Immunol 168:3072–3078, 2002
Qing X, Zavadil J, Crosby MB, Hogarth MP, Hahn BH, Mohan C, Gilkeson GS, Bottinger EP, Putterman C: Nephritogenic anti-DNA antibodies regulate gene expression in MRL/lpr mouse glomerular mesangial cells. Arthritis Rheum 54:2198–2210, 2006
Many thanks are due to Cindy Séné and Simone Forest for secretarial assistance. The authors are also grateful to Prof. Peter M. Lydyard (UCL Medical School, London, UK) for his thoughtful review of the manuscript. This work has been supported in part by a grant (#2466) of the Research Committee, University of Thessaly.
About this article
Cite this article
PAUL, G., GEORGIOS, D., JEAN-BAPTISTE, N. et al. Double Reactivity Against Actin and α-Actinin Defines a Severe Form of Autoimmune Hepatitis Type 1. J Clin Immunol 26, 495–505 (2006). https://doi.org/10.1007/s10875-006-9045-z
- anti-smooth-muscle antibodies
- active disease
- binding domain